Cargando…
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
BACKGROUND: Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this study is to create a pharmacoeconomic model to pred...
Autores principales: | Canonica, Giorgio Walter, Colombo, Giorgio Lorenzo, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Blasi, Francesco, Bucca, Caterina, Crimi, Nunzio, Paggiaro, Pierluigi, Pelaia, Girolamo, Passalaqua, Giovanni, Senna, Gianenrico, Heffler, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439414/ https://www.ncbi.nlm.nih.gov/pubmed/30937132 http://dx.doi.org/10.1016/j.waojou.2018.12.001 |
Ejemplares similares
-
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020) -
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020) -
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022) -
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017) -
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)